AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Non-Cash-Items" stands at 5.70 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025.
AbbVie Inc's third quarter result of 1.23 Billion USD for the item "Other Non Cash Items" represents a decrease of -56.37 percent compared to it's second quarter result.
Also, AbbVie Inc's third quarter result of 1.23 Billion USD for the item "Other Non Cash Items" represents an increase of 9.34 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), AbbVie Inc's third quarter result of 5.70 Billion USD for the item "Other Non Cash Items" represents an increase of 1.88 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.445 Billion United States Dollars compared to the value the year prior.
The 1 year change is -0.445 Billion United States Dollars.
The 3 year change is 1.14 Billion United States Dollars.
The 5 year change is 2.57 Billion United States Dollars.
The 10 year change is 4.41 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Non Cash Items | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Non Cash Items | 486,508,953,600.00 |
![]() | Roche Holding AG - Other Non Cash Items | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Non Cash Items | 280,205,508,085.11 |
![]() | Novartis AG - Other Non Cash Items | 255,096,620,580.91 |